Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-28 | New | $7,440,682 | $7,440,682 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Tero Pekka Alastalo | Director, Executive |
| Jenny Engerfelt | Director |
| Gabriel Poteliunaite | Director |
| Katja Rosti | Director, Executive |